All News

Pharmacies, just as expected, have showed up in meaningful ways to support their communities.

The study will evaluate ruxolitinib (Jakavi) for the treatment of COVID-19-associated cytokine storm.

The FDA’s public- and private-sector partnership will expedite thousands of units of plasma to patients with severe COVID-19 symptoms, the news release said.

Officials with the FDA have granted approval to ixekizumab (Taltz, Eli Lilly) injection, 80 mg/mL for the treatment of pediatric patients with moderate-to-severe plaque psoriasis.

Officials with the FDA have approved luspatercept-aamt (Reblozyl, Bristol Myers Squibb and Acceleron Pharma) for the treatment of anemia in adults with lower-risk myelodysplastic syndromes.

Facing disruptions in medical mask supplies, some hospital staff are re-using masks and using alternative types, according to a new survey.

Here's a roundup of the latest coronavirus-related news.

Coagulation factor VIIa (recombinant)-jncw (Sevenfact, LBF) contains an active ingredient from a genetically engineered animal.

Obesity may contribute to incident long-term prescription opioid use due to underlying pain conditions.

During times like these, we must come together and help those in need.

Rimegepant (Nurtec ODT, Biohaven Pharmaceuticals) reduced monthly migraine days in patients with episode and chronic migraine in a clinical trial.

A clinical trial funded by AstraZeneca evaluated the use of short-acting GLP-1 receptor agonists as an add-on treatment to insulin therapy in type 1 diabetes.

Officials with the FDA have requested that manufacturers of all ranitidine (Zantac) drugs, both prescription and over-the-counter, remove their products from the market. 

Bempedoic acid (Nexletol, Esperion), an oral, once-daily, non-statin low-density lipoprotein-cholesterol lowering medicine, is now available in US pharmacies.

The purpose of the project was to increase the number of influenza, pertussis, pneumococcal, and herpes zoster vaccines provided to adults.

As coronavirus cases surge nationwide, retail pharmacies are facing incredibly difficult circumstances.

Less common but more communicable than localized zoster

Ticagrelor alone, without aspirin, reduced bleeding without increasing the cardiovascular risks.

Concerns about adequate protection from COVID-19 have led to several efforts from chain pharmacies to keep pharmacy staff and employees safe.

Officials with the FDA have approved durvalumab (Imfinzi) for the first-line treatment of extensive-stage small cell lung cancer (ES-SCLC), in combination with standard-of-care (SoC) chemotherapies, in adult patients.

Alirocumab significantly reduced low-density lipoprotein cholesterol in adults with homozygous familial hypercholesterolemia, according to phase 3 data. 

Johnson & Johnson expects to initiate human clinical studies for its lead COVID-19 vaccine candidate by September 2020.

Chloroquine and hydroxychloroquine have been authorized to treat hospitalized patients with COVID-19.

Abbott’s ID NOW COVID-19 test is able to deliver results in as little as 5 minutes.

Things to know about the root cause of chickenpox and shingles

Here’s a roundup of the latest coronavirus-related news from this week. 

Officials with the FDA have granted approval to ozanimod (Zeposia, Bristol Myers Squibb) for the treatment of relapsing multiple sclerosis.

Gilead has now asked the FDA to rescind its orphan drug status for the potential COVID-19 therapy.

Health care providers should look out for more than just respiratory diagnoses in patients when it comes to influenza-associated complications, according to a recent study. 

In a joint statement, the American Medical Association (AMA), American Pharmacists Association (APhA), and American Society of Health-System Pharmacists (ASHP) have communicated concerns regarding the inappropriate ordering, prescribing, or dispensing of treatments for COVID-19.